Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Schering Plough Corporation published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 35
» View latimes.com items only
    Jan 5, 2012 | Los Angeles Times
  1. ‘Pariah’ director Dee Rees' odd path: bunion pads to Spike Lee

    24 Frames
    Dee Rees, the writer and director behind the new lesbian coming-of-age film “Pariah,” spent her formative career years marketing panty liners and bunion pads for Procter & Gamble and Dr. Scholl’s before a chance encounter prompted a...
  2. Jun 30, 2008 |Story| Los Angeles Times
  3. Claims that shoe insoles relieve back pain are unsupported

    <b>The product:</b> The human spine is an amazing piece of equipment: On request, it can sway gracefully or withstand thousands of pounds of force. But that versatility comes with a price. At some point, just about everyone suffers significant back pain, and  ends up searching for relief.
    Special to The Times
    The product: The human spine is an amazing piece of equipment: On request, it can sway gracefully or withstand thousands of pounds of force. But that versatility comes with a price. At some point, just about everyone suffers significant back pain, and...

    Tags: Education, Pharmaceuticals, University of California, Los Angeles, Flat Feet, Feet

  4. Nov 15, 2009 | Los Angeles Times
  5. Vytorin trial shows little or no benefit against heart disease [Updated]

    Booster Shots
    For the second time in as many years, a large clinical trial has found that the key ingredient in the heavily advertised drug Vytorin provides little or no benefit in preventing heart disease compared to a competing product. The ingredient......
  6. May 21, 2007 |Story| Los Angeles Times
  7. Not right for everyone

    WHEN coronary arteries grow dangerously narrow, the solution &#8212; increasingly &#8212; is to prop open the walls with a device called a drug-eluting stent. Now two new studies are adding fuel to a growing debate about whether these stents are being overused, with ill consequences for patients.
    Times Staff Writer
    WHEN coronary arteries grow dangerously narrow, the solution — increasingly — is to prop open the walls with a device called a drug-eluting stent. Now two new studies are adding fuel to a growing debate about whether these stents are being...

    Tags: Millennium Pharmaceuticals Incorporated, Colleges and Universities, Medical Research, Drugs and Medicines, Health

  8. Apr 7, 2008 |Story| Los Angeles Times
  9. A handle on heart disease?

    The cholesterol drug did absolutely everything it was supposed to do -- except for demonstrably improving the health of the people who took it.
    Los Angeles Times Staff Writer
    The cholesterol drug did absolutely everything it was supposed to do -- except for demonstrably improving the health of the people who took it. That was the conclusion reached about the popular drug Vytorin in a study published online last week in the...

    Tags: Science and Technology, University of California, Los Angeles, Liver, High Cholesterol, Health

  10. Jan 7, 2007 |Story| Los Angeles Times
  11. Dark cloud over good works of Gates Foundation

    Ebocha, Nigeria &#8212; Justice Eta, 14 months old, held out his tiny thumb.
    Times Staff Writers
    Ebocha, Nigeria — Justice Eta, 14 months old, held out his tiny thumb. An ink spot certified that he had been immunized against polio and measles, thanks to a vaccination drive supported by the Bill & Melinda Gates Foundation. But polio is not the...

    Tags: Standards, Foreign Aid, Science and Technology, Career and Workplace, Finance

  12. Jan 7, 2007 |Story| Los Angeles Times
  13. Foundation investments

    A sampling of the Gates Foundation's largest investments*: More than $1.5 billion Berkshire Hathaway Inc.** Canadian government Between $1 billion and $1.5 billion Fannie Mae German government Between $100 million and $1 billion Abbott...

    Tags: National Government, Social Issues, Archer Daniels Midland Incorporated, Berkshire Hathaway Incorporated, Merck & Company Incorporated

  14. Jun 14, 2011 |Story| AP Member Choice Complete
  15. New rules aim to cut confusion on sunscreen claims

    Help is on the way to consumers confused by the jumble of sun protection numbers and other claims on sunscreens.
    AP Health Writer
    Help is on the way to consumers confused by the jumble of sun protection numbers and other claims on sunscreens. Currently, standards of protection apply only to one part of the sun's spectrum, ultraviolet B rays, which cause sunburn. Under new rules...

    Tags: Merck & Company Incorporated, Food and Drug Administration, Skin Cancer, Physical Conditions, Economy, Business and Finance

  16. Apr 29, 2011 |Story| Hola Hoy
  17. Oct 29, 2010 |Story| Hola Hoy
  18. Nov 30, 2010 |Story| Hola Hoy
  19. Jun 24, 2010 |Story| Associated Press
 1  2 3Next >
Original site for Schering Plough Corporation topic gallery.
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Schering Plough Corporation Photos
named Thomas J. Sabatino, Jr., executive vice president...
(August 22, 2011)
Thomas J. Sabatino, Jr., executive vice president, general counsel and corporate secretary, Walgreen Co.
is buying Schering-Plough Corp. for $41.1 billion in a...
(March 11, 2009)
Recent company layoffs - Schering-Plough
Businessmen arrive at the New York Stock Exchange on Mo...
(March 9, 2009)
Wall Street woes